» Articles » PMID: 33082228

Transcriptional and Proteomic Insights into the Host Response in Fatal COVID-19 Cases

Abstract

Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, has resulted thus far in greater than 933,000 deaths worldwide; yet disease pathogenesis remains unclear. Clinical and immunological features of patients with COVID-19 have highlighted a potential role for changes in immune activity in regulating disease severity. However, little is known about the responses in human lung tissue, the primary site of infection. Here we show that pathways related to neutrophil activation and pulmonary fibrosis are among the major up-regulated transcriptional signatures in lung tissue obtained from patients who died of COVID-19 in Wuhan, China. Strikingly, the viral burden was low in all samples, which suggests that the patient deaths may be related to the host response rather than an active fulminant infection. Examination of the colonic transcriptome of these patients suggested that SARS-CoV-2 impacted host responses even at a site with no obvious pathogenesis. Further proteomics analysis validated our transcriptome findings and identified several key proteins, such as the SARS-CoV-2 entry-associated protease cathepsins B and L and the inflammatory response modulator S100A8/A9, that are highly expressed in fatal cases, revealing potential drug targets for COVID-19.

Citing Articles

Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation.

Shivshankar P, Mueller-Ortiz S, Domozhirov A, Bi W, Collum S, Doursout M Respir Res. 2025; 26(1):68.

PMID: 40016722 PMC: 11866606. DOI: 10.1186/s12931-025-03152-6.


Neutrophils Display Novel Partners of Cytosolic Proliferating Cell Nuclear Antigen Involved in Interferon Response in COVID-19 Patients.

Pesenti L, de Oliveira Formiga R, Tamassia N, Gardiman E, Chable de La Heronniere F, Gasperini S J Innate Immun. 2025; 17(1):154-175.

PMID: 40015257 PMC: 11867639. DOI: 10.1159/000543633.


Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.

Sabit H, Arneth B, Altrawy A, Ghazy A, Abdelazeem R, Adel A Biomedicines. 2025; 13(2).

PMID: 40002898 PMC: 11852909. DOI: 10.3390/biomedicines13020485.


Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients.

Pedreanez A, Mosquera-Sulbaran J, Tene D Diabetol Int. 2024; 15(4):732-744.

PMID: 39469543 PMC: 11512988. DOI: 10.1007/s13340-024-00746-1.


Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.

Dragotakes Q, Johnson P, Buras M, Carter R, Joyner M, Bloch E Proc Natl Acad Sci U S A. 2024; 121(41):e2414957121.

PMID: 39352932 PMC: 11474081. DOI: 10.1073/pnas.2414957121.


References
1.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

2.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

3.
Saintigny P, Peng S, Zhang L, Sen B, Wistuba I, Lippman S . Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther. 2012; 11(9):2021-32. PMC: 3438283. DOI: 10.1158/1535-7163.MCT-12-0030. View

4.
Wisniewski J, Dus K, Mann M . Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins. Proteomics Clin Appl. 2012; 7(3-4):225-33. DOI: 10.1002/prca.201200046. View

5.
Gardinassi L, DeSouza-Vieira T, da Silva N, Garcia G, Borges V, Campos R . Molecular signatures of neutrophil extracellular traps in human visceral leishmaniasis. Parasit Vectors. 2017; 10(1):285. PMC: 5460406. DOI: 10.1186/s13071-017-2222-5. View